Eliza M. Lauer

Freiburg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Spatial and multi-omic profiling reveals pericyte-derived CCL19 as a key prognostic factor in CNS lymphoma.

Spatial and multi-omic profiling reveals pericyte-derived CCL19 as a key prognostic factor in CNS lymphoma.

Journal: HemaSphere

Published: January 20, 2026

The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous System.

The Phase Ib VenObi CNS Study: Chemotherapy-Free Treatment with Venetoclax and Obinutuzumab for Relapsed/Refractory Primary Large B-Cell Lymphoma of the Central Nervous System.

Journal: Cancers

Published: December 23, 2025

Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS Lymphoma.

Role of Geriatric Assessment Scores as Predictors of Intensive Therapy Feasibility and Survival in Elderly Patients with Primary CNS Lymphoma.

Journal: Cancers

Published: October 17, 2025

Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid.

Guiding clinical management of patients with CNS lymphomas by minimal-invasive detection of ctDNA in cerebrospinal fluid.

Journal: Leukemia

Published: January 24, 2025

Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.

Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.

Journal: Neuro-oncology

Published: September 15, 2023

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial.

Age-adjusted high-dose chemotherapy followed by autologous stem cell transplantation or conventional chemotherapy with R-MP as first-line treatment in elderly primary CNS lymphoma patients - the randomized phase III PRIMA-CNS trial.

Journal: BMC cancer

Published: June 29, 2023

Clinical applications of circulating tumor DNA in central nervous system lymphoma.

Clinical applications of circulating tumor DNA in central nervous system lymphoma.

Journal: Seminars in hematology

Published: June 19, 2023

Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.

Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation-Immune signature correlates with response.

Journal: British journal of haematology

Published: June 03, 2023

Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.

Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 21, 2022

Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research.

Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational research.

Journal: Leukemia

Published: July 20, 2021

Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis.

Ibrutinib in patients with relapsed/refractory central nervous system lymphoma: A retrospective single-centre analysis.

Journal: British journal of haematology

Published: May 27, 2020

Contribution of the Cholinergic System to Verbal Memory Performance in Mild Cognitive Impairment.

Contribution of the Cholinergic System to Verbal Memory Performance in Mild Cognitive Impairment.

Journal: Journal of Alzheimer's disease : JAD

Published: June 25, 2016

Showing 1-12 of 15

Last Updated: 09/26/2026